GREEN CROSS MEDICAL SCIENCE CORPORATION Financials Green Cross Medical Science Corporation
Equities
A142280
KR7142280007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,085 KRW | 0.00% |
|
-0.37% | -14.36% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 118,544 | 110,603 | 330,756 | 152,316 | 121,856 | 100,562 |
| Enterprise Value (EV) 1 | 134,535 | 109,576 | 344,319 | 187,455 | 134,506 | 117,398 |
| P/E ratio | -11 x | -3.58 x | 49.2 x | -7.18 x | -34 x | 62.9 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.37 x | 1.18 x | 2.92 x | 1.5 x | 1.08 x | 1.07 x |
| EV / Revenue | 1.56 x | 1.16 x | 3.04 x | 1.84 x | 1.19 x | 1.25 x |
| EV / EBITDA | -40.1 x | -74.5 x | 46.8 x | -11.5 x | 58.5 x | 22.9 x |
| EV / FCF | -21.1 x | -5.43 x | -26.1 x | -11.3 x | 5.04 x | -14.2 x |
| FCF Yield | -4.74% | -18.4% | -3.83% | -8.84% | 19.9% | -7.03% |
| Price to Book | 7.69 x | 2.23 x | 5.86 x | 4.22 x | 3.66 x | 2.91 x |
| Nbr of stocks (in thousands) | 9,560 | 21,067 | 21,067 | 21,067 | 21,082 | 21,082 |
| Reference price 2 | 12,400 | 5,250 | 15,700 | 7,230 | 5,780 | 4,770 |
| Announcement Date | 3/19/19 | 3/16/20 | 3/16/21 | 3/18/22 | 3/20/23 | 3/19/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 86,322 | 94,085 | 113,377 | 101,675 | 113,109 | 94,011 |
| EBITDA 1 | -3,352 | -1,471 | 7,361 | -16,333 | 2,299 | 5,125 |
| EBIT 1 | -5,828 | -4,443 | 4,199 | -20,164 | -1,808 | 1,272 |
| Operating Margin | -6.75% | -4.72% | 3.7% | -19.83% | -1.6% | 1.35% |
| Earnings before Tax (EBT) 1 | -9,428 | -16,350 | 7,238 | -21,108 | -2,951 | 1,865 |
| Net income 1 | -10,711 | -16,205 | 6,717 | -21,202 | -3,581 | 1,797 |
| Net margin | -12.41% | -17.22% | 5.92% | -20.85% | -3.17% | 1.91% |
| EPS 2 | -1,126 | -1,468 | 318.8 | -1,006 | -169.9 | 75.80 |
| Free Cash Flow 1 | -6,382 | -20,172 | -13,193 | -16,568 | 26,702 | -8,253 |
| FCF margin | -7.39% | -21.44% | -11.64% | -16.29% | 23.61% | -8.78% |
| FCF Conversion (EBITDA) | - | - | - | - | 1,161.63% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/19/19 | 3/16/20 | 3/16/21 | 3/18/22 | 3/20/23 | 3/19/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 15,991 | - | 13,562 | 35,139 | 12,650 | 16,836 |
| Net Cash position 1 | - | 1,028 | - | - | - | - |
| Leverage (Debt/EBITDA) | -4.77 x | - | 1.842 x | -2.151 x | 5.503 x | 3.285 x |
| Free Cash Flow 1 | -6,382 | -20,172 | -13,193 | -16,568 | 26,702 | -8,253 |
| ROE (net income / shareholders' equity) | -52% | -48.4% | 12.9% | -44% | -8.31% | 5.17% |
| ROA (Net income/ Total Assets) | -5.85% | -3.63% | 2.7% | -12.5% | -1.18% | 0.85% |
| Assets 1 | 183,071 | 445,950 | 248,890 | 169,276 | 304,288 | 211,447 |
| Book Value Per Share 2 | 1,613 | 2,353 | 2,680 | 1,714 | 1,577 | 1,636 |
| Cash Flow per Share 2 | 405.0 | 412.0 | 213.0 | 87.50 | 415.0 | 272.0 |
| Capex 1 | 5,101 | 22,460 | 2,554 | 3,598 | 3,426 | 5,632 |
| Capex / Sales | 5.91% | 23.87% | 2.25% | 3.54% | 3.03% | 5.99% |
| Announcement Date | 3/19/19 | 3/16/20 | 3/16/21 | 3/18/22 | 3/20/23 | 3/19/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -14.36% | 62.94M | |
| -1.29% | 12.64B | |
| -0.47% | 8.46B | |
| +5.68% | 5.66B | |
| +22.61% | 5.27B | |
| -2.03% | 4.49B | |
| -53.56% | 3.11B | |
| +19.30% | 2.87B | |
| +33.07% | 2.31B | |
| -8.42% | 2.23B |
- Stock Market
- Equities
- A142280 Stock
- Financials Green Cross Medical Science Corporation
